Not just coverage - if trial endpoints are met (e.g the cartilage has regrown as shown from MRIs), we shouldn’t settle for anything less than provisional approval via TGA. I would be very upset if following positive results nothing tangible happened.
Stem Cell News, page-490
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $53.89M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 30.0¢ | $13.45K | 44.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27229 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 6000 | 2 |
View Market Depth
| Last trade - 15.56pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
30.0¢ |
Change
0.000 ( 1.64 %) |
||||
| Open | High | Low | Volume | ||
| 31.0¢ | 31.0¢ | 30.0¢ | 16729 | ||
| Last updated 13.34pm 07/06/2024 ? | |||||
| CYP (ASX) Chart |